SPECIALTIES

Vaccine

Axon Clinical sites have extensive experience in vaccine trials, with over 400 completed studies. Access to diverse patient populations, high volume enrollment strategies and PBMC capabilities are just a few success criteria. More information about experience and vaccine capabilities are described below.

Vaccine Experience

408

Total Completed Studies

24,936

Enrolled Study Participants

13

Vaccine Sites

29

BARDA Funded Programs

13

Active IBC Registered Sites

3

Sties with PBMC Capabilities

Vaccine Experience: Indication

Avian Influenza
Anthrax
C-Diff
Celiac Disease
Chikungunya
Dengue

Ebola
HCMV
Hepatitis B
Herpes
Zoster
HPV

Influenza
Meningitis
Norovirus
Pandemic
Influenza
(H7N1)

Pediatric Influenza
Pneumonia
Respiratory Syncytial Virus
Seasonal Influenza
Smallpox

Swine Influenza H1N1
Tetanus
Diptheria
Pertussis
COVID-19

Respiratory Vaccine Experience

125

Completed Influenza Studies

30

Completed Pneumonia Studies

26

Completed RSV Studies

19

Completed COVID-19 Studies

CAPABILITIES

Patients​

• Highly Diverse demographics

​• Group enrollment

• Access to Pediatric and Elderly Populations

Operations​

• Rapid Study Start Up

• Creative use of social media and other recruitment strategies

• Innovative approaches to high volume enrollment

Facilities​

• Controlled access for Study Drug with broad range of temperature storage

• PBMC Capabilities and Experience

• Fully compliant with all regulations